Stefano Romeo (S Romeo)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 61

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Alimentary pharmacology & therapeutics

Research square

Arteriosclerosis, thrombosis, and vascular biology

University of Gothenburg

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Gothenburg Jun 27 2013

Sweden

Professor in Molecular and Clinical Medicine :: Molecular and Clinical Medicine

Publications

Antonio De Vincentis, Federica Tavaglione, Shinichi Namba, Masahiro Kanai, Yukinori Okada, Yoichiro Kamatani, Samantha Maurotti, Claudio Pedone, Raffaele Antonelli Incalzi, Luca Vittorio Valenti, Stefano Romeo, Umberto Vespasiani-Gentilucci
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population. Alimentary pharmacology & therapeutics (2024)
Antonio De Vincentis, Federica Tavaglione, Shinichi Namba, Masahiro Kanai, Yukinori Okada, Yoichiro Kamatani, Samantha Maurotti, Claudio Pedone, Raffaele Antonelli Incalzi, Luca Vittorio Valenti, Stefano Romeo, Umberto Vespasiani-Gentilucci
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population. Alimentary pharmacology & therapeutics 59 (11) (2024)
Wen Yang, Fahim Ebrahimi, Stefano Romeo, Magnus Holmer, Johan Vessby, Mattias Ekstedt, Jonas F Ludvigsson, Ying Shang, Hannes Hagström
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Tanmoy Dutta, Kavitha Sasidharan, Daniel Lindén, Stefano Romeo
Response to letter to the editor regarding 'Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome'. Liver international : official journal of the International Association for the Study of the Liver 44 (8) (2024)
Tanmoy Dutta, Kavitha Sasidharan, Ester Ciociola, Grazia Pennisi, Francesca R Noto, Lohitesh Kovooru, Tobias Kroon, Anna Lindblom, Yue Du, Mohammad Pirmoradian, Simonetta Wallin, Rosellina Margherita Mancina, Daniel Lindén, Stefano Romeo
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Alessandro Cherubini, Mahnoosh Ostadreza, Oveis Jamialahmadi, Serena Pelusi, Eniada Rrapaj, Elia Casirati, Giulia Passignani, Marjan Norouziesfahani, Elena Sinopoli, Guido A Baselli, Clara Meda, Paola Dongiovanni, Daniele Dondossola, Neil Youngson, Aikaterini Tourna, Shilpa Chokshi, Elisabetta Bugianesi, null null, Sara Della Torre, Daniele Prati, Stefano Romeo, Luca Vittorio Valenti
Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women. Nature medicine (2024)
Salvatore Petta, Giovanni Targher, Stefano Romeo, Utpal B Pajvani, Ming-Hua Zheng, Alessio Aghemo, Luca Vittorio Valenti
The first MASH drug therapy on the horizon: Current perspectives of resmetirom. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Salvatore Petta, Giovanni Targher, Stefano Romeo, Utpal B Pajvani, Ming-Hua Zheng, Alessio Aghemo, Luca Vittorio Valenti
The first MASH drug therapy on the horizon: Current perspectives of resmetirom. Liver international : official journal of the International Association for the Study of the Liver (2024)
Tanmoy Dutta, Kavitha Sasidharan, Daniel Lindén, Stefano Romeo
Response to letter to the editor regarding 'Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome'. Liver international : official journal of the International Association for the Study of the Liver (2024)
Antonio De Vincentis, Federica Tavaglione, Shinichi Namba, Masahiro Kanai, Yukinori Okada, Yoichiro Kamatani, Samantha Maurotti, Claudio Pedone, Raffaele Antonelli Incalzi, Luca Vittorio Valenti, Stefano Romeo, Umberto Vespasiani-Gentilucci
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population. Alimentary pharmacology & therapeutics 59 (11) (2024)
Tanmoy Dutta, Kavitha Sasidharan, Ester Ciociola, Grazia Pennisi, Francesca R Noto, Lohitesh Kovooru, Tobias Kroon, Anna Lindblom, Yue Du, Mohammad Pirmoradian, Simonetta Wallin, Rosellina Margherita Mancina, Daniel Lindén, Stefano Romeo
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Wen Yang, Fahim Ebrahimi, Stefano Romeo, Magnus Holmer, Johan Vessby, Mattias Ekstedt, Jonas F Ludvigsson, Ying Shang, Hannes Hagström
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Grazia Pennisi, Samantha Maurotti, Ester Ciociola, Oveis Jamialahmadi, Giorgio Bertolazzi, Angela Mirarchi, Per-Olof Bergh, Francesca Scionti, Rosellina Margherita Mancina, Rocco Spagnuolo, Claudio Tripodo, Jan Boren, Salvatore Petta, Stefano Romeo
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization. Arteriosclerosis, thrombosis, and vascular biology 44 (5) (2024)
Salvatore Petta, Giovanni Targher, Stefano Romeo, Utpal B Pajvani, Ming-Hua Zheng, Alessio Aghemo, Luca Vittorio Valenti
The first MASH drug therapy on the horizon: Current perspectives of resmetirom. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Tanmoy Dutta, Kavitha Sasidharan, Ester Ciociola, Grazia Pennisi, Francesca R Noto, Lohitesh Kovooru, Tobias Kroon, Anna Lindblom, Yue Du, Mohammad Pirmoradian, Simonetta Wallin, Rosellina Margherita Mancina, Daniel Lindén, Stefano Romeo
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome. Liver international : official journal of the International Association for the Study of the Liver (2024)
Federica Tavaglione, Giuseppe Marafioti, Stefano Romeo, Oveis Jamialahmadi
Machine learning reveals the contribution of lipoproteins to liver triglyceride content and inflammation. The Journal of clinical endocrinology and metabolism (2024)
Grazia Pennisi, Samantha Maurotti, Ester Ciociola, Oveis Jamialahmadi, Giorgio Bertolazzi, Angela Mirarchi, Per-Olof Bergh, Francesca Scionti, Rosellina Margherita Mancina, Rocco Spagnuolo, Claudio Tripodo, Jan Boren, Salvatore Petta, Stefano Romeo
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization. Arteriosclerosis, thrombosis, and vascular biology 44 (5) (2024)
Tanmoy Dutta, Kavitha Sasidharan, Ester Ciociola, Grazia Pennisi, Francesca R Noto, Lohitesh Kovooru, Tobias Kroon, Anna Lindblom, Yue Du, Mohammad Pirmoradian, Simonetta Wallin, Rosellina Margherita Mancina, Daniel Lindén, Stefano Romeo
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Salvatore Petta, Giovanni Targher, Stefano Romeo, Utpal B Pajvani, Ming-Hua Zheng, Alessio Aghemo, Luca Vittorio Valenti
The first MASH drug therapy on the horizon: Current perspectives of resmetirom. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Antonio De Vincentis, Federica Tavaglione, Shinichi Namba, Masahiro Kanai, Yukinori Okada, Yoichiro Kamatani, Samantha Maurotti, Claudio Pedone, Raffaele Antonelli Incalzi, Luca Vittorio Valenti, Stefano Romeo, Umberto Vespasiani-Gentilucci
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population. Alimentary pharmacology & therapeutics 59 (11) (2024)
Wen Yang, Fahim Ebrahimi, Stefano Romeo, Magnus Holmer, Johan Vessby, Mattias Ekstedt, Jonas F Ludvigsson, Ying Shang, Hannes Hagström
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD. Liver international : official journal of the International Association for the Study of the Liver (2024)
Tanmoy Dutta, Kavitha Sasidharan, Ester Ciociola, Grazia Pennisi, Francesca R Noto, Lohitesh Kovooru, Tobias Kroon, Anna Lindblom, Yue Du, Mohammad Pirmoradian, Simonetta Wallin, Rosellina Margherita Mancina, Daniel Lindén, Stefano Romeo
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Grazia Pennisi, Samantha Maurotti, Ester Ciociola, Oveis Jamialahmadi, Giorgio Bertolazzi, Angela Mirarchi, Per-Olof Bergh, Francesca Scionti, Rosellina Margherita Mancina, Rocco Spagnuolo, Claudio Tripodo, Jan Boren, Salvatore Petta, Stefano Romeo
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization. Arteriosclerosis, thrombosis, and vascular biology (2024)
Stefano Romeo, Oveis Jamialahmadi, Antonio De Vincentis, Federica Tavaglione, Francesco Malvestiti, Ruifang Li-Gao, Rosellina Margherita Mancina, Marcus Alvarez, Kyla Gelev, Samantha Maurotti, Umberto Vespasiani-Gentilucci, Frits Richard Rosendaal, Julia Kozlitina, Päivi Pajukanta, François Pattou, Luca Vittorio Valenti
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease. Research square (2024)
Stefano Romeo, Oveis Jamialahmadi, Antonio De Vincentis, Federica Tavaglione, Francesco Malvestiti, Ruifang Li-Gao, Rosellina Margherita Mancina, Marcus Alvarez, Kyla Gelev, Samantha Maurotti, Umberto Vespasiani-Gentilucci, Frits Richard Rosendaal, Julia Kozlitina, Päivi Pajukanta, François Pattou, Luca Vittorio Valenti
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease. Research square (2024)
Wen Yang, Fahim Ebrahimi, Stefano Romeo, Magnus Holmer, Johan Vessby, Mattias Ekstedt, Jonas F Ludvigsson, Ying Shang, Hannes Hagström
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Stefano Romeo, Oveis Jamialahmadi, Antonio De Vincentis, Federica Tavaglione, Francesco Malvestiti, Ruifang Li-Gao, Rosellina Margherita Mancina, Marcus Alvarez, Kyla Gelev, Samantha Maurotti, Umberto Vespasiani-Gentilucci, Frits Richard Rosendaal, Julia Kozlitina, Päivi Pajukanta, François Pattou, Luca Vittorio Valenti
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease. Research square (2024)
Federica Tavaglione, Oveis Jamialahmadi, Charlotta Ljungman, Stefano Romeo
Reply to: "Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank". Liver international : official journal of the International Association for the Study of the Liver 43 (6) (2023)
Rosaria M Pipitone, Francesco Malvestiti, Grazia Pennisi, Oveis Jamialahmadi, Paola Dongiovanni, Giorgio Bertolazzi, Jussi Pihlajamäki, Hannele Yki-Järvinen, Umberto Vespasiani-Gentilucci, Federica Tavaglione, Samantha Maurotti, Cristiana Bianco, Gabriele Di Maria, Marco Enea, Anna Ludovica Fracanzani, Vesa Kärjä, Giulia Lupo, Ville Männistö, Marica Meroni, Roberto Piciotti, Sami Qadri, Rossella Zito, Antonio Craxì, Vito Di Marco, Calogero Cammà, Claudio Tripodo, Luca Vittorio Valenti, Stefano Romeo, Salvatore Petta, Stefania Grimaudo
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver (2023)
Alessandro Cherubini, Mahnoosh Ostadreza, Oveis Jamialahmadi, Serena Pelusi, Eniada Rrapaj, Elia Casirati, Giulia Passignani, Marjan Norouziesfahani, Elena Sinopoli, Guido A Baselli, Clara Meda, Paola Dongiovanni, Daniele Dondossola, Neil Youngson, Aikaterini Tourna, Shilpa Chokshi, Elisabetta Bugianesi, null null, Sara Della Torre, Daniele Prati, Stefano Romeo, Luca Vittorio Valenti
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women. Nature medicine (2023)
Jonathan G Stine, Stefano Romeo
Sweating it out: How physical activity can combat high genetic risk for nonalcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 43 (8) (2023)
Rosaria M Pipitone, Francesco Malvestiti, Grazia Pennisi, Oveis Jamialahmadi, Paola Dongiovanni, Giorgio Bertolazzi, Jussi Pihlajamäki, Hannele Yki-Järvinen, Umberto Vespasiani-Gentilucci, Federica Tavaglione, Samantha Maurotti, Cristiana Bianco, Gabriele Di Maria, Marco Enea, Anna Ludovica Fracanzani, Vesa Kärjä, Giulia Lupo, Ville Männistö, Marica Meroni, Roberto Piciotti, Sami Qadri, Rossella Zito, Antonio Craxì, Vito Di Marco, Calogero Cammà, Claudio Tripodo, Luca Vittorio Valenti, Stefano Romeo, Salvatore Petta, Stefania Grimaudo
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver (2023)
Luca Vittorio Valenti, Alessio Aghemo, Alejandro Forner, Salvatore Petta, Stefano Romeo, Pierre Nahon
Measuring the impact of the updated Steatotic liver disease nomenclature and definition. Liver international : official journal of the International Association for the Study of the Liver 43 (11) (2023)
Rosaria M Pipitone, Francesco Malvestiti, Grazia Pennisi, Oveis Jamialahmadi, Paola Dongiovanni, Giorgio Bertolazzi, Jussi Pihlajamäki, Hannele Yki-Järvinen, Umberto Vespasiani-Gentilucci, Federica Tavaglione, Samantha Maurotti, Cristiana Bianco, Gabriele Di Maria, Marco Enea, Anna Ludovica Fracanzani, Vesa Kärjä, Giulia Lupo, Ville Männistö, Marica Meroni, Roberto Piciotti, Sami Qadri, Rossella Zito, Antonio Craxì, Vito Di Marco, Calogero Cammà, Claudio Tripodo, Luca Vittorio Valenti, Stefano Romeo, Salvatore Petta, Stefania Grimaudo
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver (2023)
Federica Tavaglione, Oveis Jamialahmadi, Luca Vittorio Valenti, Stefano Romeo
Fatty liver disease genetic risk variants and interference on sex hormones. Liver international : official journal of the International Association for the Study of the Liver 43 (5) (2023)
Umberto Vespasiani-Gentilucci, Luca Vittorio Valenti, Stefano Romeo
Usefulness of PNPLA3 variant for predicting hepatic events in steatotic liver disease: a matter of ethnicity or baseline risk? Liver international : official journal of the International Association for the Study of the Liver 43 (10) (2023)
Federica Tavaglione, Oveis Jamialahmadi, Luca Vittorio Valenti, Stefano Romeo
Fatty liver disease genetic risk variants and interference on sex hormones. Liver international : official journal of the International Association for the Study of the Liver 43 (5) (2023)
Federica Tavaglione, Oveis Jamialahmadi, Charlotta Ljungman, Stefano Romeo
Reply to: "Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank". Liver international : official journal of the International Association for the Study of the Liver 43 (6) (2023)
Oveis Jamialahmadi, Federica Tavaglione, Araz Rawshani, Charlotta Ljungman, Stefano Romeo
Fatty Liver Disease, Heart Rate, and Cardiac Remodelling: Evidence from the UK Biobank. Liver international : official journal of the International Association for the Study of the Liver (2023)
Rosellina Margherita Mancina, Kavitha Sasidharan, Anna Lindblom, Ying Wei, Ester Ciociola, Oveis Jamialahmadi, Piero Pingitore, Anne-Christine Andréasson, Giovanni Pellegrini, Guido A Baselli, Ville Männistö, Jussi Pihlajamäki, Vesa Kärjä, Stefania Grimaudo, Ilaria Marini, Marco Maggioni, Barbara Becattini, Federica Tavaglione, Carly Dix, Marie Castaldo, Stephanie Klein, Mark Perelis, Francois Pattou, Dorothée Thuillier, Violeta Raverdy, Paola Dongiovanni, Anna Ludovica Fracanzani, Felix Stickel, Jochen Hampe, Stephan Buch, Panu K Luukkonen, Daniele Prati, Hannele Yki-Järvinen, Salvatore Petta, Chao Xing, Clemens Schafmayer, Elmar Aigner, Christian Datz, Richard G Lee, Luca Valenti, Daniel Lindén, Stefano Romeo
PSD3 downregulation confers protection against fatty liver disease. Nature metabolism 4 (1) (2022)
Grazia Pennisi, Rosaria Maria Pipitone, Marco Enea, Antonio De Vincentis, Salvatore Battaglia, Vito Di Marco, Vincenzo Di Martino, Federica Spatola, Federica Tavaglione, Umberto Vespasiani-Gentilucci, Rossella Zito, Stefano Romeo, Calogero Cammà, Antonio Craxì, Stefania Grimaudo, Salvatore Petta
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease. Hepatology communications 6 (5) (2022)
Stefano Romeo
ACAT2 as a novel therapeutic target to treat fatty liver disease. Journal of internal medicine 292 (2) (2022)
Jake P Mann, Stefano Romeo, Luca Vittorio Valenti
Lipid droplets as the genetic nexus of fatty liver. Liver international : official journal of the International Association for the Study of the Liver 42 (12) (2022)
Magnus Holmer, Mattias Ekstedt, Patrik Nasr, Robin Zenlander, Axel Wester, Federica Tavaglione, Stefano Romeo, Stergios Kechagias, Per Stål, Hannes Hagström
Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up. Liver international : official journal of the International Association for the Study of the Liver 42 (12) (2022)
Stefano Romeo, Luca Vittorio Valenti
African genetic ancestry and protection against fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 42 (10) (2022)
Luca Vittorio Valenti, Stefano Romeo, Utpal B Pajvani
A genetic hypothesis for burnt-out steatohepatitis. Liver international : official journal of the International Association for the Study of the Liver 41 (12) (2022)
Stephan Buch, Hamish Innes, Philipp Ludwig Lutz, Hans Dieter Nischalke, Jens U Marquardt, Janett Fischer, Karl Heinz Weiss, Jonas Rosendahl, Astrid Marot, Marcin Krawczyk, Markus Casper, Frank Lammert, Florian Eyer, Arndt Vogel, Silke Marhenke, Johann von Felden, Rohini Sharma, Stephen Rahul Atkinson, Andrew McQuillin, Jacob Nattermann, Clemens Schafmayer, Andre Franke, Christian P Strassburg, Marcella Rietschel, Heidi Altmann, Stefan Sulk, Veera Raghavan Thangapandi, Mario Brosch, Carolin Lackner, Rudolf E Stauber, Peter Lemmer, Alexander Link, Thomas Reiberger, Mattias Mandorfer, Georg Semmler, Bernhard Scheiner, Christian Datz, Stefano Romeo, Stefano Ginanni Corradini, William Lucien Irving, Joanne R Morling, Indra Neil Guha, Eleanor Barnes, M Azim Ansari, Jocelyn Quistrebert, Luca Vittorio Valenti, Sascha A Müller, Marsha Yvonne Morgan, Jean-François Dufour, Jonel Trebicka, Thomas Berg, Pierre Deltenre, Sebastian Mueller, Jochen Hampe, Felix Stickel
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study. Gut (2022)
Antonio De Vincentis, Federica Tavaglione, Rocco Spagnuolo, Roberta Pujia, Dario Tuccinardi, Gianluca Mascianà, Antonio Picardi, Raffaele Antonelli Incalzi, Luca Valenti, Stefano Romeo, Umberto Vespasiani-Gentilucci
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank. International journal of obesity (2005) (2021)
Stefania Grimaudo, Paola Dongiovanni, Jussi Pihlajamäki, Mohammed Eslam, Hannele Yki-Järvinen, Rosaria Maria Pipitone, Guido Baselli, Calogero Cammà, Vito Di Marco, Marco Enea, Miriam Longo, Grazia Pennisi, Daniele Prati, Rossella Zito, Anna Ludovica Fracanzani, Antonio Craxì, Jacob George, Stefano Romeo, Luca Vittorio Valenti, Salvatore Petta
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 41 (11) (2021)
Federica Tavaglione, Antonio De Vincentis, Vincenzo Bruni, Ida Francesca Gallo, Simone Carotti, Dario Tuccinardi, Giuseppe Spagnolo, Ester Ciociola, Rosellina Margherita Mancina, Oveis Jamialahmadi, Rossella D'Alessio, Bruna Bottazzi, Silvia Manfrini, Antonio Picardi, Giuseppe Perrone, Paolo Pozzilli, Marco Caricato, Umberto Vespasiani-Gentilucci, Stefano Romeo
Accuracy of Controlled Attenuation Parameter for Assessing Liver Steatosis in Individuals With Morbid Obesity Before Bariatric Surgery. Liver international : official journal of the International Association for the Study of the Liver (2021)
Guido Alessandro Baselli, Paola Dongiovanni, Raffaela Rametta, Marica Meroni, Serena Pelusi, Marco Maggioni, Sara Badiali, Piero Pingitore, Samantha Maurotti, Tiziana Montalcini, Alice Emma Taliento, Daniele Prati, Giorgio Rossi, Anna Ludovica Fracanzani, Rosellina Margherita Mancina, Stefano Romeo, Luca Vittorio Valenti
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker. Gut 69 (10) (2020)
Yuki Tanaka, Yuta Shimanaka, Andrea Caddeo, Takuya Kubo, Yanli Mao, Tetsuya Kubota, Naoto Kubota, Toshimasa Yamauchi, Rosellina Margherita Mancina, Guido Baselli, Panu Luukkonen, Jussi Pihlajamäki, Hannele Yki-Järvinen, Luca Vittorio Valenti, Hiroyuki Arai, Stefano Romeo, Nozomu Kono
LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover. Gut 70 (1) (2020)
Cristiana Bianco, Stefano Romeo, Salvatore Petta, Michelle T Long, Luca Vittorio Valenti
MAFLD vs NAFLD: Let the contest begin! Liver international : official journal of the International Association for the Study of the Liver 40 (9) (2020)
Stefania Grimaudo, Stefano Bartesaghi, Raffaela Rametta, Fabio Marra, Rosellina Margherita Mancina, Jussi Pihlajamäki, Dorota Kakol-Palm, Anne-Christine Andréasson, Paola Dongiovanni, Anna Ludovica Fracanzani, Giulia Lori, Ville Männistö, Giovanni Pellegrini, Mohammad Bohlooly-Y, Grazia Pennisi, Rosaria Maria Pipitone, Rocco Spagnuolo, Antonio Craxì, Daniel Lindén, Luca Vittorio Valenti, Stefano Romeo, Salvatore Petta
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD. Liver international : official journal of the International Association for the Study of the Liver 41 (2) (2020)
Stefan Stender, Stefano Romeo
HSD17B13 as a promising therapeutic target against chronic liver disease. Liver international : official journal of the International Association for the Study of the Liver 40 (4) (2020)
Antonio De Vincentis, Rosellina Margherita Mancina, Jussi Pihlajamäki, Ville T Männistö, Salvatore Petta, Paola Dongiovanni, Anna Ludovica Fracanzani, Luca Vittorio Valenti, Federica Tavaglione, Stefano Romeo, Umberto Vespasiani-Gentilucci
Genetic variants in the MTHFR are not associated with fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 40 (8) (2020)
Ville T Männistö, Dorota Kaminska, Pirjo Käkelä, Mikko Neuvonen, Mikko Niemi, Marcus Alvarez, Päivi Pajukanta, Stefano Romeo, Max Nieuwdorp, Albert K Groen, Jussi Pihlajamäki
Protein Phosphatase 1 Regulatory Subunit 3B Genotype at rs4240624 Has a Major Effect on Gallbladder Bile Composition. Hepatology communications 5 (2) (2020)
Björn Carlsson, Daniel Lindén, Gabriella Brolén, Mathias Liljeblad, Mikael Bjursell, Stefano Romeo, Stephen Caldwell
Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis. Alimentary pharmacology & therapeutics 51 (12) (2020)
Stefano Romeo
Don't forget to ask how mum and dad are doing. Liver international : official journal of the International Association for the Study of the Liver 39 (4) (2019)
Sebastian Prill, Andrea Caddeo, Guido Baselli, Oveis Jamialahmadi, Paola Dongiovanni, Raffaela Rametta, Kajsa P Kanebratt, Arturo Pujia, Piero Pingitore, Rosellina Margherita Mancina, Daniel Lindén, Carl Whatling, Annika Janefeldt, Mikael Kozyra, Magnus Ingelman-Sundberg, Luca Valenti, Tommy B Andersson, Stefano Romeo
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids. Scientific reports 9 (1) (2019)
Luca Vittorio Valenti, Stefano Romeo
Editorial: new insights into the relationship between the intestine and non-alcoholic fatty liver-is "fatty gut" involved in disease progression? Alimentary pharmacology & therapeutics 46 (3) (2017)

Stefano Romeo.css-eqlu8i{font-size:small;padding-left:4px;} (S Romeo)

Publication Activity (10 Years)

Top Topics

Top Venues

Stefano Romeo (S Romeo)